Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF), a leading gold explorer in the Guiana Shield, has released a reminder for holders of outstanding common share purchase warrants issued on July 8, 2022; the company is reminding…
Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), will be presenting results from its latest Alzheimer’s study at the Alzheimer’s Association International…
Clene (NASDAQ: CLNN), a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), recently participated in the 72nd Emerging…
Electric utilities have become the engine moving solar energy adoption in the United States, accounting for 11.8 gigawatts of new energy capacity in the first three months of 2024, according to a June 5 report…
Freight Technologies (NASDAQ: FRGT), a technology company whose custom-developed Fr8App, an industry-leading freight-matching platform powered by artificial intelligence (“AI”) and machine learning, offers a real-time portal for business-to-business (“B2B”) cross-border shipping and domestic shipping, participated…
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced the hiring of a Contract Research Organization (“CRO”) for its third human pilot study. This marks a milestone for the company, notably…
Secure identification and digital monitoring solutions company SuperCom (NASDAQ: SPCB) recently secured a new contract for monitoring youths transitioning through California’s justice system, demonstrating SuperCom’s competitiveness and ability to build on its reputation with existing…
Rob McEwen, CEO of McEwen Mining (NYSE: MUX) (TSX: MUX), an asset rich diversified gold and silver producer in the Americas, recently spoke at the NYC SME’s 9th Annual Current Trends in Mining Finance Conference, where…
Mass spectrometry (“MS”) is becoming a transformative analytical technique that has revolutionized how materials are tested and processed in various industries, such as petrochemical. The supreme accuracy of MS in analyzing the molecular structure, purity,…
InMed Pharmaceuticals (NASDAQ: INM), a is a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors. InMed’s pipeline consists of three separate programs in the…
Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF), a leading gold explorer in the Guiana Shield, has scheduled an annual general and special shareholders meeting. The meeting will be held July 9, 2024, with agenda items that…
McEwen Mining (NYSE: MUX) (TSX: MUX) is an asset rich diversified gold and silver producer in the Americas with a large exposure to copper through its McEwen Copper subsidiary. The company’s Chairman and Chief Owner,…
PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, recently completed its three registration/validation batches of PAX-101, an IV formulation of suramin. “This accomplishment marks a significant step toward submitting a…
While some headlines in the past few months make it seem like the electric vehicle market is in trouble, a recent “Car and Driver” article forecasts that EV sales are just getting started. Mullen Automotive (NASDAQ:…
Annovis Bio (NYSE: ANVS), a late-stage, clinical-drug-platform company developing novel therapies for neurodegenerative disorders such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), is reporting the results of its recent phase 2/3 Alzheimer’s study. The study…
SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, is scheduled to present at the 72nd Emerging Growth Conference, hosted by leading independent small cap media portal EmergingGrowth.com. Taking place on…
InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates, will be featured in this week’s Emerging Growth Conference. The conference is slated for June 12–13,…
Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, today announced the addition of zero-emissions commercial vehicle dealership, Eco Auto, a Boston, Massachusetts-area dedicated EV dealer. As Mullen’s newest franchise dealer, Eco Auto will cover…
With environmental concerns becoming an increasing priority, more states, companies, and consumers are paying attention to — and prioritizing — environmentally friendly products and practices. Mullen Automotive (NASDAQ: MULN), an emerging EV manufacturer, shares this commitment to being…
Recent Achievements Investment Considerations Annovis Bio (NYSE: ANVS) is a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (“AD”) and Parkinson’s Disease (“PD”). Annovis Bio stands out by developing…